retatrutide triple agonist glp-1 gip glucagon phase 3 2025 Lilly's delivers up to 71.2 lbs of weight loss Lilly's triple agonist achieves 16.8%

Description

The ongoing SURPASS-CVOT trial (ClinicalTrials.gov registration no

Conservation of Glucagon Like Peptide-1 Level With Liraglutide and Linagilptin Protects the Kidney Against Angiotensin II-Induced Tissue Fibrosis in Rats

Continued research, cautious clinical integration, and clear differentiation between adult and pediatric data will be essential to ensuring safe and effective use of these agents in adolescent obesity care

If you experience persistent nausea or sulfur burps (the rotten egg taste sometimes associated with GLP-1 use), tell your coordinator at the start

According to CBC News, Canadians currently pay anywhere from $300 to $500 per month for GLP-1 medications, including semaglutide brands such as Ozempic and Wegovy [Source: cbc.ca/news/health/ozempic-trumprx-cheaper-insurance-9.6970197]